CERO THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Property and Other Taxes Payable
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Increase (Decrease) in Property and Other Taxes Payable of $6.10 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPropertyAndOtherTaxesPayable · last filed 2024-04-02
- CERO THERAPEUTICS HOLDINGS, INC. increase (decrease) in property and other taxes payable for the quarter ending 2023-09-30 was -$13.90K, a 140.95% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. increase (decrease) in property and other taxes payable for the quarter ending 2023-06-30 was -$3.53K, a 119.74% decline year-over-year.
- CERO THERAPEUTICS HOLDINGS, INC. increase (decrease) in property and other taxes payable for the quarter ending 2023-03-31 was $23.53K.
- CERO THERAPEUTICS HOLDINGS, INC. increase (decrease) in property and other taxes payable for the quarter ending 2022-12-31 was -$101.84K.
- CERO THERAPEUTICS HOLDINGS, INC. increase (decrease) in property and other taxes payable for fiscal 2022 was -$80.32K.
| Period end | Increase (Decrease) in Property and Other Taxes Payable 1 month | Increase (Decrease) in Property and Other Taxes Payable 3 month | Increase (Decrease) in Property and Other Taxes Payable 4 month | Increase (Decrease) in Property and Other Taxes Payable 6 month | Increase (Decrease) in Property and Other Taxes Payable 7 month | Increase (Decrease) in Property and Other Taxes Payable 9 month | Increase (Decrease) in Property and Other Taxes Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | -$13.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$17.43K derived: sum of 2 quarters · filed 2023-11-09 | $6.10K 10-Q · filed 2023-11-09 | -$95.74K derived: sum of 4 quarters · filed 2024-04-02 | |||
| 2023-06-30 | -$3.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $20.00K 10-Q · filed 2023-08-14 | -$81.84K derived: sum of 3 quarters · filed 2024-04-02 | -$47.89K derived: sum of 4 quarters · filed 2024-04-02 | |||
| 2023-03-31 | $23.53K 10-Q · filed 2023-05-12 | -$78.31K derived: sum of 2 quarters · filed 2024-04-02 | -$44.36K derived: sum of 3 quarters · filed 2024-04-02 | -$26.47K derived: sum of 4 quarters · filed 2024-04-02 | |||
| 2022-12-31 | -$101.84K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | -$67.89K derived: sum of 2 quarters · filed 2024-04-02 | -$50.00K derived: sum of 3 quarters · filed 2024-04-02 | -$80.32K 10-K · filed 2024-04-02 | |||
| 2022-09-30 | $33.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $51.84K derived: sum of 2 quarters · filed 2023-11-09 | $21.51K 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | $17.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$12.43K 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | -$30.32K 10-Q · filed 2023-05-12 | ||||||
| 2021-12-31 | $80.32K 10-K · filed 2023-03-24 | ||||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |